The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Respiratory Virus Vaccines Market Research Report 2025
Synopsis
Respiratory virus vaccines are used to prevent viruses from harming the human body. There are a variety of vaccines against pancreatitis, rubella, measles, influenza, coronavirus and other viruses. The components of the vaccine are also differentiated according to age.
The global Respiratory Virus Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Virus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Virus Vaccines.
Report Scope
The Respiratory Virus Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Virus Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Virus Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Limited
Sanofi
AstraZeneca
Merck & Co., Inc.
GlaxoSmithKline plc
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Sinovac Biotech Ltd.
Segment by Type
Inactivated Vaccines
Live-attenuated Vaccines
Recombinant Vaccines
Segment by Application
Physician's Office
Hospitals
Clinics
Pharmacies/Stores
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Virus Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Virus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Respiratory virus vaccines are used to prevent viruses from harming the human body. There are a variety of vaccines against pancreatitis, rubella, measles, influenza, coronavirus and other viruses. The components of the vaccine are also differentiated according to age.
The global Respiratory Virus Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Virus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Virus Vaccines.
Report Scope
The Respiratory Virus Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Virus Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Virus Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Limited
Sanofi
AstraZeneca
Merck & Co., Inc.
GlaxoSmithKline plc
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Sinovac Biotech Ltd.
Segment by Type
Inactivated Vaccines
Live-attenuated Vaccines
Recombinant Vaccines
Segment by Application
Physician's Office
Hospitals
Clinics
Pharmacies/Stores
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Virus Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Virus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Respiratory Virus Vaccines Market Overview
1.1 Product Overview and Scope of Respiratory Virus Vaccines
1.2 Respiratory Virus Vaccines Segment by Type
1.2.1 Global Respiratory Virus Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Vaccines
1.2.3 Live-attenuated Vaccines
1.2.4 Recombinant Vaccines
1.3 Respiratory Virus Vaccines Segment by Application
1.3.1 Global Respiratory Virus Vaccines Market Value by Application: (2024-2030)
1.3.2 Physician's Office
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Pharmacies/Stores
1.4 Global Respiratory Virus Vaccines Market Size Estimates and Forecasts
1.4.1 Global Respiratory Virus Vaccines Revenue 2019-2030
1.4.2 Global Respiratory Virus Vaccines Sales 2019-2030
1.4.3 Global Respiratory Virus Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Respiratory Virus Vaccines Market Competition by Manufacturers
2.1 Global Respiratory Virus Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Respiratory Virus Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Respiratory Virus Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Respiratory Virus Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Respiratory Virus Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Respiratory Virus Vaccines, Product Type & Application
2.7 Respiratory Virus Vaccines Market Competitive Situation and Trends
2.7.1 Respiratory Virus Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Respiratory Virus Vaccines Players Market Share by Revenue
2.7.3 Global Respiratory Virus Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Respiratory Virus Vaccines Retrospective Market Scenario by Region
3.1 Global Respiratory Virus Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Respiratory Virus Vaccines Global Respiratory Virus Vaccines Sales by Region: 2019-2030
3.2.1 Global Respiratory Virus Vaccines Sales by Region: 2019-2024
3.2.2 Global Respiratory Virus Vaccines Sales by Region: 2025-2030
3.3 Global Respiratory Virus Vaccines Global Respiratory Virus Vaccines Revenue by Region: 2019-2030
3.3.1 Global Respiratory Virus Vaccines Revenue by Region: 2019-2024
3.3.2 Global Respiratory Virus Vaccines Revenue by Region: 2025-2030
3.4 North America Respiratory Virus Vaccines Market Facts & Figures by Country
3.4.1 North America Respiratory Virus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Respiratory Virus Vaccines Sales by Country (2019-2030)
3.4.3 North America Respiratory Virus Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Respiratory Virus Vaccines Market Facts & Figures by Country
3.5.1 Europe Respiratory Virus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Respiratory Virus Vaccines Sales by Country (2019-2030)
3.5.3 Europe Respiratory Virus Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Respiratory Virus Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Respiratory Virus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Respiratory Virus Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Respiratory Virus Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Respiratory Virus Vaccines Market Facts & Figures by Country
3.7.1 Latin America Respiratory Virus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Respiratory Virus Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Respiratory Virus Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Respiratory Virus Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Respiratory Virus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Respiratory Virus Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Respiratory Virus Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Respiratory Virus Vaccines Sales by Type (2019-2030)
4.1.1 Global Respiratory Virus Vaccines Sales by Type (2019-2024)
4.1.2 Global Respiratory Virus Vaccines Sales by Type (2025-2030)
4.1.3 Global Respiratory Virus Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Respiratory Virus Vaccines Revenue by Type (2019-2030)
4.2.1 Global Respiratory Virus Vaccines Revenue by Type (2019-2024)
4.2.2 Global Respiratory Virus Vaccines Revenue by Type (2025-2030)
4.2.3 Global Respiratory Virus Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Respiratory Virus Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Respiratory Virus Vaccines Sales by Application (2019-2030)
5.1.1 Global Respiratory Virus Vaccines Sales by Application (2019-2024)
5.1.2 Global Respiratory Virus Vaccines Sales by Application (2025-2030)
5.1.3 Global Respiratory Virus Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Respiratory Virus Vaccines Revenue by Application (2019-2030)
5.2.1 Global Respiratory Virus Vaccines Revenue by Application (2019-2024)
5.2.2 Global Respiratory Virus Vaccines Revenue by Application (2025-2030)
5.2.3 Global Respiratory Virus Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Respiratory Virus Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL Limited
6.1.1 CSL Limited Corporation Information
6.1.2 CSL Limited Description and Business Overview
6.1.3 CSL Limited Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Limited Respiratory Virus Vaccines Product Portfolio
6.1.5 CSL Limited Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Respiratory Virus Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Respiratory Virus Vaccines Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Merck & Co., Inc.
6.4.1 Merck & Co., Inc. Corporation Information
6.4.2 Merck & Co., Inc. Description and Business Overview
6.4.3 Merck & Co., Inc. Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co., Inc. Respiratory Virus Vaccines Product Portfolio
6.4.5 Merck & Co., Inc. Recent Developments/Updates
6.5 GlaxoSmithKline plc
6.5.1 GlaxoSmithKline plc Corporation Information
6.5.2 GlaxoSmithKline plc Description and Business Overview
6.5.3 GlaxoSmithKline plc Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline plc Respiratory Virus Vaccines Product Portfolio
6.5.5 GlaxoSmithKline plc Recent Developments/Updates
6.6 Serum Institute of India Pvt. Ltd.
6.6.1 Serum Institute of India Pvt. Ltd. Corporation Information
6.6.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.6.3 Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Product Portfolio
6.6.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.7 Bharat Biotech
6.6.1 Bharat Biotech Corporation Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bharat Biotech Respiratory Virus Vaccines Product Portfolio
6.7.5 Bharat Biotech Recent Developments/Updates
6.8 Sinovac Biotech Ltd.
6.8.1 Sinovac Biotech Ltd. Corporation Information
6.8.2 Sinovac Biotech Ltd. Description and Business Overview
6.8.3 Sinovac Biotech Ltd. Respiratory Virus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sinovac Biotech Ltd. Respiratory Virus Vaccines Product Portfolio
6.8.5 Sinovac Biotech Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Respiratory Virus Vaccines Industry Chain Analysis
7.2 Respiratory Virus Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Respiratory Virus Vaccines Production Mode & Process
7.4 Respiratory Virus Vaccines Sales and Marketing
7.4.1 Respiratory Virus Vaccines Sales Channels
7.4.2 Respiratory Virus Vaccines Distributors
7.5 Respiratory Virus Vaccines Customers
8 Respiratory Virus Vaccines Market Dynamics
8.1 Respiratory Virus Vaccines Industry Trends
8.2 Respiratory Virus Vaccines Market Drivers
8.3 Respiratory Virus Vaccines Market Challenges
8.4 Respiratory Virus Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Respiratory Virus Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Respiratory Virus Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Respiratory Virus Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Respiratory Virus Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Respiratory Virus Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Respiratory Virus Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Respiratory Virus Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Respiratory Virus Vaccines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Respiratory Virus Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Respiratory Virus Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Respiratory Virus Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Respiratory Virus Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Respiratory Virus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Virus Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Respiratory Virus Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Respiratory Virus Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Respiratory Virus Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Respiratory Virus Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Respiratory Virus Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Respiratory Virus Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Respiratory Virus Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Respiratory Virus Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Respiratory Virus Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Respiratory Virus Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Respiratory Virus Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Respiratory Virus Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Respiratory Virus Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Respiratory Virus Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Respiratory Virus Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Respiratory Virus Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Respiratory Virus Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Respiratory Virus Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Respiratory Virus Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Respiratory Virus Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Respiratory Virus Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Respiratory Virus Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Respiratory Virus Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Respiratory Virus Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Respiratory Virus Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Respiratory Virus Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Respiratory Virus Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Respiratory Virus Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Respiratory Virus Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Respiratory Virus Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Respiratory Virus Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Respiratory Virus Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Respiratory Virus Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Respiratory Virus Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Respiratory Virus Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Respiratory Virus Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Respiratory Virus Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Respiratory Virus Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Respiratory Virus Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Respiratory Virus Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Respiratory Virus Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Respiratory Virus Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Respiratory Virus Vaccines Price (US$/Unit) by Type (2019-2024)
Table 59. Global Respiratory Virus Vaccines Price (US$/Unit) by Type (2025-2030)
Table 60. Global Respiratory Virus Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Respiratory Virus Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Respiratory Virus Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Respiratory Virus Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Respiratory Virus Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Respiratory Virus Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Respiratory Virus Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Respiratory Virus Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Respiratory Virus Vaccines Price (US$/Unit) by Application (2019-2024)
Table 69. Global Respiratory Virus Vaccines Price (US$/Unit) by Application (2025-2030)
Table 70. CSL Limited Corporation Information
Table 71. CSL Limited Description and Business Overview
Table 72. CSL Limited Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. CSL Limited Respiratory Virus Vaccines Product
Table 74. CSL Limited Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Respiratory Virus Vaccines Product
Table 79. Sanofi Recent Developments/Updates
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. AstraZeneca Respiratory Virus Vaccines Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Merck & Co., Inc. Corporation Information
Table 86. Merck & Co., Inc. Description and Business Overview
Table 87. Merck & Co., Inc. Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merck & Co., Inc. Respiratory Virus Vaccines Product
Table 89. Merck & Co., Inc. Recent Developments/Updates
Table 90. GlaxoSmithKline plc Corporation Information
Table 91. GlaxoSmithKline plc Description and Business Overview
Table 92. GlaxoSmithKline plc Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. GlaxoSmithKline plc Respiratory Virus Vaccines Product
Table 94. GlaxoSmithKline plc Recent Developments/Updates
Table 95. Serum Institute of India Pvt. Ltd. Corporation Information
Table 96. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 97. Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Serum Institute of India Pvt. Ltd. Respiratory Virus Vaccines Product
Table 99. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 100. Bharat Biotech Corporation Information
Table 101. Bharat Biotech Description and Business Overview
Table 102. Bharat Biotech Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bharat Biotech Respiratory Virus Vaccines Product
Table 104. Bharat Biotech Recent Developments/Updates
Table 105. Sinovac Biotech Ltd. Corporation Information
Table 106. Sinovac Biotech Ltd. Description and Business Overview
Table 107. Sinovac Biotech Ltd. Respiratory Virus Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sinovac Biotech Ltd. Respiratory Virus Vaccines Product
Table 109. Sinovac Biotech Ltd. Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Respiratory Virus Vaccines Distributors List
Table 113. Respiratory Virus Vaccines Customers List
Table 114. Respiratory Virus Vaccines Market Trends
Table 115. Respiratory Virus Vaccines Market Drivers
Table 116. Respiratory Virus Vaccines Market Challenges
Table 117. Respiratory Virus Vaccines Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Respiratory Virus Vaccines
Figure 2. Global Respiratory Virus Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Respiratory Virus Vaccines Market Share by Type in 2023 & 2030
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Live-attenuated Vaccines Product Picture
Figure 6. Recombinant Vaccines Product Picture
Figure 7. Global Respiratory Virus Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Respiratory Virus Vaccines Market Share by Application in 2023 & 2030
Figure 9. Physician's Office
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Pharmacies/Stores
Figure 13. Global Respiratory Virus Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Respiratory Virus Vaccines Market Size (2019-2030) & (US$ Million)
Figure 15. Global Respiratory Virus Vaccines Sales (2019-2030) & (K Units)
Figure 16. Global Respiratory Virus Vaccines Average Price (US$/Unit) & (2019-2030)
Figure 17. Respiratory Virus Vaccines Report Years Considered
Figure 18. Respiratory Virus Vaccines Sales Share by Manufacturers in 2023
Figure 19. Global Respiratory Virus Vaccines Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Respiratory Virus Vaccines Players: Market Share by Revenue in 2023
Figure 21. Respiratory Virus Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Respiratory Virus Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Respiratory Virus Vaccines Sales Market Share by Country (2019-2030)
Figure 24. North America Respiratory Virus Vaccines Revenue Market Share by Country (2019-2030)
Figure 25. United States Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Respiratory Virus Vaccines Sales Market Share by Country (2019-2030)
Figure 28. Europe Respiratory Virus Vaccines Revenue Market Share by Country (2019-2030)
Figure 29. Germany Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Respiratory Virus Vaccines Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Respiratory Virus Vaccines Revenue Market Share by Region (2019-2030)
Figure 36. China Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Respiratory Virus Vaccines Sales Market Share by Country (2019-2030)
Figure 46. Latin America Respiratory Virus Vaccines Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Respiratory Virus Vaccines Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Respiratory Virus Vaccines Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Respiratory Virus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Respiratory Virus Vaccines by Type (2019-2030)
Figure 56. Global Revenue Market Share of Respiratory Virus Vaccines by Type (2019-2030)
Figure 57. Global Respiratory Virus Vaccines Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Respiratory Virus Vaccines by Application (2019-2030)
Figure 59. Global Revenue Market Share of Respiratory Virus Vaccines by Application (2019-2030)
Figure 60. Global Respiratory Virus Vaccines Price (US$/Unit) by Application (2019-2030)
Figure 61. Respiratory Virus Vaccines Value Chain
Figure 62. Respiratory Virus Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
